Back to TSHA
MORGAN STANLEY TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
24
Latest value
$1.5M
Q2 2026
Peak value
$109M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $708K |
| Q3 2025 | $53.7M |
| Q3 2025 | $8K |
| Q3 2025 | $8.7M |
| Q3 2025 | $56 |
| Q3 2025 | $18K |
| Q3 2025 | $10K |
| Q4 2025 | $748K |
| Q4 2025 | $88M |
| Q4 2025 | $10.2M |
| Q4 2025 | $62K |
| Q4 2025 | $454K |
| Q1 2026 | $608K |
| Q1 2026 | $73.4M |
| Q1 2026 | $854 |
| Q1 2026 | $6.1M |
| Q1 2026 | $80K |
| Q1 2026 | $96K |
| Q2 2026 | $1.2M |
| Q2 2026 | $109M |
| Q2 2026 | $1K |
| Q2 2026 | $451K |
| Q2 2026 | $172K |
| Q2 2026 | $1.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.5M | 217.9K | — | — |
| Q2 2026 | $172K | 25.3K | — | — |
| Q2 2026 | $451K | 66.2K | — | — |
| Q2 2026 | $1K | 166 | — | — |
| Q2 2026 | $109M | 16.00M | — | — |
| Q2 2026 | $1.2M | 176.8K | — | — |
| Q1 2026 | $96K | 21.4K | — | — |
| Q1 2026 | $80K | 17.9K | — | — |
| Q1 2026 | $6.1M | 1.37M | — | — |
| Q1 2026 | $854 | 191 | — | — |
| Q1 2026 | $73.4M | 16.42M | — | — |
| Q1 2026 | $608K | 136.0K | — | — |
| Q4 2025 | $454K | 82.5K | — | — |
| Q4 2025 | $62K | 11.3K | — | — |
| Q4 2025 | $10.2M | 1.85M | — | — |
| Q4 2025 | $88M | 16.00M | — | — |
| Q4 2025 | $748K | 136.0K | — | — |
| Q3 2025 | $10K | 3.0K | — | — |
| Q3 2025 | $18K | 5.4K | — | — |
| Q3 2025 | $56 | 17 | — | — |
| Q3 2025 | $8.7M | 2.65M | — | — |
| Q3 2025 | $8K | 2.3K | — | — |
| Q3 2025 | $53.7M | 16.43M | — | — |
| Q3 2025 | $708K | 216.5K | — | — |